ReviewEye (London, England)2023
The application and progression of CRISPR/Cas9 technology in ophthalmological diseases.
Xumeng Hu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
24 papers cite it
this paperpooled itcites it
ReviewEye (London, England)2023
Xumeng Hu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.